Sort
23,748 grants matching “melanoma”
Interferon-gamma limits the effectiveness of peptide vaccines for cancer
$302,919Esteban Celis · Augusta University · R01 · FY2014 · CA
Investigation of the WRAMP Structure, a Mechanism for Directional Cell Migration
$302,885Natalie G Ahn · University Of Colorado · R01 · FY2019 · GM
Manipulation of Tumor Specific Immunity
$302,825Hans Schreiber · University Of Chicago · R01 · FY2015 · CA
Tumor Suppressor Genes in Heritable Melanoma Models
$302,817Rodney S Nairn · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
Proj 1 - Targeting Evolving Therapy Resistance
$302,817Yael P Mosse · Children'S Hosp Of Philadelphia · P01 · FY2020 · CA
Synergistically Acting Targeted Therapeutics for Melanoma
$302,813Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2014 · CA
POLYAMINE ANALOG AND INHIBITOR REGULATION OF CELL CYCLE
$302,748Roswell Park Cancer Institute Corp · R01 · FY2002 · CA
Discovery of Alpha-MSH Analogs for Skin Cancer Prevention
$302,740Zalfa Abdel-Malek · University Of Cincinnati · R01 · FY2007 · CA
CELL MEDIATED IMMUNITY TO OCULAR TUMORS
$302,716Schepens Eye Research Institute · R01 · FY2001 · EY
Project 2 - PCG-1 Signaling and Mitochondrial Stress in Melanoma
$302,687Marcus W Bosenberg · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2018 · CA
Project 2 - PCG-1 Signaling and Mitochondrial Stress in Melanoma
$302,687Marcus W Bosenberg · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2020 · CA
CD8+ HELPER-INDEPENDENT T CELLS IN TUMOR THERAPY
$302,544Peter A Cohen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2006 · CA
Host's Genes that Control Lymphocyte Infiltration of Tumors
$302,508Peter Demant · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA
QUALITY OF LIFE--THE COLLABORATIVE OCULAR MELANOMA STUDY
$302,500Johns Hopkins University · U10 · FY2001 · EY
Cancer cell telomere dynamics and responses to perturbations
$302,453Elizabeth H Blackburn · University Of California, San Francisco · R01 · FY2007 · CA
Ras Oncoprotein-Targeted Therapy for Cancer
$302,435Douglas V Faller · Boston University Medical Campus · R01 · FY2007 · CA
Ras Oncoprotein-Targeted Therapy for Cancer
$302,435Douglas V Faller · Boston University Medical Campus · R01 · FY2009 · CA
Ras Oncoprotein-Targeted Therapy for Cancer
$302,435Douglas V Faller · Boston University Medical Campus · R01 · FY2008 · CA
Targets of Immune-Mediated Tumor Destruction
$302,403Glenn Dranoff · Dana-Farber Cancer Inst · R01 · FY2006 · CA
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to RAF inhibitors
$302,328Andrew E Aplin · Thomas Jefferson University · R01 · FY2013 · CA
Peptide Vaccination Targeting Tumor-Specific IDH1R132H Mutation for Brain Tumors
$302,291John H Sampson · Duke University · P50 · FY2014 · CA
Genetic Predictors for DNA Repair Phenotype in CMM
$302,276Qingyi Wei · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
Templated Chemistry for RNA Analysis
$302,206Eric T. Kool · Stanford University · R01 · FY2016 · GM
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
$302,203Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2012 · CA
Clinical Development of HU14.18-IL2 Targeted Therapy
$302,121Paul M Sondel · University Of Wisconsin-Madison · R01 · FY2014 · CA